INSEAD-Day

Google to invest $6.4bn

The investment is its biggest-ever in Germany.

Pfizer poised to buy Metsera

The pharma giant improved its offer to $10bn.

Ozempic maker lowers outlook

The company posted tepid Q3 results.

Kimberly-Clark to buy Kenvue

The deal is valued at $48.7 billion.

BYD Q3 profit down 33%

This was a 33% year-on-year decrease.

Sulaiman Group’s profit soars

A front view of Dr. Sulaiman AL-Habib Hospital in AL Qassim. (Omnia Health)
  • The company's revenue posted 16 percent jump to $1.06 billion for the six months period ended 30th June 2022
  • The hospital operator's board recommended distributing $80 million in dividends at SR0.86 per share during the second quarter of 2022

Dr. Sulaiman Al Habib Group has recorded a 22 percent increase in profit to $210 million for the first half of 2022, fueled by higher revenue.

The company’s revenue increased 16 percent, reaching $1.06 billion for the six months period ended 30th June 2022, compared to $906 million in the corresponding period of the previous year, driven by growth in the hospital segment.

Following the announcement, its board recommended distributing $80 million in dividends at SR0.86 per share during the second quarter of 2022.